Benzinga Psychedelics Capital Conference

This article was originally published on Cannabis.net and appears here with permission. A funny thing happened on the way to Fort Lauderdale having Biblical flooding after the Benzinga Cannabis Capital Conference in Miami, with the airport closed for 48 hours, Cannabis.net got to stick around and...

In the current psychedelics landscape, one of the most important topics is compound legality.  While it's possible that MDMA-assisted therapy will eventually be federally approved in the U.S., what should investors consider when looking at a prospective business? The 2023 edition of...

Revolutionizing Psychedelics: 2 Industry Leaders Team Up On Clinical-Grade MDMA Capsules MDXX-class molecules producer PharmAla Biotech Holdings Inc. and natural psychedelics developer Filament Health Corp's (OTCMKTS: FLHLF) partnership is seeing the release of GMP-compliant MDMA capsules for...

At the second edition of Benzinga’s Psychedelics Capital Conference, held in sunny Miami, leaders from four major ketamine therapy companies shared their optimistic insights and guidance about the industry. Revitalist L&W’s Kathryn Walker (OTC: RVLWF), Jeffrey Becker (Bexson...

Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutionizing psychedelic therapy as a promising new approach for treating mental health conditions and how clinical data is crucial to pulling institutional...

“Investing in real estate can help expand experiential medicines like ketamine and MDMA for treating PTSD and build infrastructure for upcoming FDA-approved therapies,” said Daniel Carcillo, founder and CEO at Wesana Health Holdings Inc (OTCQB: WSNAF) at Benzinga Psychedelics...

It's human nature to fear what we cannot understand. The best way to conquer that fear is with knowledge, Brock Pierce told the crowd at Benzinga Psychedelics Capital Conference on Thursday in Miami Beach. The crypto billionaire, economist and philanthropist who serves as...

The global psychedelics market of drugs such as psilocybin, ketamine and LSD is booming and there are plenty of ways to get involved in the space. Several esteemed professionals in the space talked about ways to get exposure Thursday (April 13) at Benzinga's...

MDMA Therapy For PTSD Nearing Legalization In U.S. And Worldwide, MAPS Releases Promising Data MAPS Public Benefit Corporation shared positive topline results from an observational follow-up of its two Phase 3 studies on the long-term safety and efficacy of MDMA-assisted therapy for PTSD.  The...

MDXX-class molecules producer PharmAla Biotech Holdings Inc. and natural psychedelics developer Filament Health Corp's (OTCQB: FLHLF) partnership is seeing the release of GMP-compliant MDMA capsules for distribution to clinical trials and authorized patients in Canada and worldwide....

Since the beginning of the new wave in medicine and public opinion, there has been a retaking of psychedelics-assisted therapy for the treatment of mental health conditions commonly known as Psychedelics Renaissance. With this, there has been an explosive number of companies working...

Cannabis is a psychedelic that belongs to the group of mind-manifesting substances, according to Dr. Julie Holland. "When you get high on cannabis, you can see your thoughts differently, and it can give you a bigger perspective on life," she said in an interview with Rena Sherbill...

Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin is a constitutional right under the Canadian Charter of Rights and Freedoms. In 2020, Health...

As the attachment to both tobacco and alcohol is deeply rooted and likely intertwined with other human and societal factors, it is evident these behaviors are complex to analyze.  And yet, the near future seems to hold hope for those ready and willing to disengage from these...

The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey. Scheduled for April 13th, this year's edition follows the well-established Cannabis Capital Conference (CCC) and will take...